Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-25 @ 5:32 PM
Study NCT ID:
NCT00698204
Status:
COMPLETED
Last Update Posted:
2014-06-05
First Post:
2008-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cox-2 Inhibition in Radiation-induced Oral Mucositis
Sponsor:
UConn Health
Organization:
Study Overview
Official Title:
Cyclooxygenase-2 Inhibition in Radiation-Induced Oral Mucositis
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Oral mucositis refers to ulcerative lesions of the oral mucosa that occur due to radiation therapy given for treatment of head and neck cancer. These lesions are painful, compromise nutrition and quality of life and may necessitate interruptions in radiation therapy, thus adversely affecting cancer therapy outcomes. This study examined the use of an anti-inflammatory medicine to reduce pain and severity of oral mucositis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| GCRC 487 | OTHER | UCHC Clinical Research Center | View | |
| COXAON-0509-150 | OTHER | Pfizer, Inc. | View | |
| K23DE016946-05 | NIH | None | https://reporter.nih.gov/quic… | View |